You have 9 free searches left this month | for more free features.

Rhenium Nanoliposome

Showing 1 - 12 of 12

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Leptomeningeal Metastasis Trial in Dallas, San Antonio (186RNL)

Recruiting
  • Leptomeningeal Metastasis
  • Dallas, Texas
  • +1 more
Jul 12, 2022

Glioma Trial (Retreatment Rhenium Liposome)

Not yet recruiting
  • Glioma
  • Retreatment Rhenium Liposome
  • (no location specified)
Jul 12, 2022

Glioma Trial in Dallas, Houston, San Antonio (Rhenium Liposome Treatment)

Recruiting
  • Glioma
  • Rhenium Liposome Treatment
  • Dallas, Texas
  • +2 more
Nov 3, 2021

Non-melanoma Skin Cancer Trial in Sydney, Tugun (Rhenium-SCT)

Recruiting
  • Non-melanoma Skin Cancer
  • Rhenium-SCT
  • Sydney, New South Wales, Australia
  • +1 more
Mar 30, 2022

Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia, Refractory Trial in New York, Hershey, Charlottesville (Ceramide

Not yet recruiting
  • Acute Myeloid Leukemia, in Relapse
  • Acute Myeloid Leukemia, Refractory
  • Ceramide NanoLiposome (Ceraxa)
  • New York, New York
  • +2 more
Jan 15, 2021

Arthritis Trial in Canada (Radiosynoviorthesis)

Completed
  • Arthritis
  • Calgary, Alberta, Canada
  • +8 more
Apr 9, 2021

Prostate Cancer Metastatic to Bone Trial in Amsterdam (Radium-223 chloride, Rhenium-188-HEDP)

Active, not recruiting
  • Prostate Cancer Metastatic to Bone
  • Amsterdam, Netherlands
    VU University Medical Center
Nov 16, 2020

Cancer, Carcinoma, Solid Tumors Trial in Baltimore, Charleston, Charlottesville (Ceramide NanoLiposome)

Unknown status
  • Cancer
  • +3 more
  • Ceramide NanoLiposome
  • Baltimore, Maryland
  • +2 more
Feb 26, 2019

Small Cell Lung Cancer (SCLC), Neuroendocrine (NE) Tumors, Large Cell Neuroendocrine (NE) Tumors Trial in Baltimore (Rhenium Re

Withdrawn
  • Small Cell Lung Cancer (SCLC)
  • +2 more
  • Rhenium Re 188-P2045
  • Baltimore, Maryland
    University of Maryland Marlene & Stewart Greenebaum Cancer Cente
Oct 15, 2019

Lung Tumors, NSCLC, Carcinoma, Small Cell Trial in Iowa City, Baltimore (Rhenium (Re 188 P2045, BAY86-5284))

Unknown status
  • Lung Neoplasms
  • +3 more
  • Rhenium (Re 188 P2045, BAY86-5284)
  • Iowa City, Iowa
  • +1 more
Jan 9, 2019

NSCLC Trial (hMAb BIWA 4)

Completed
  • Carcinoma, Non-Small-Cell Lung
  • hMAb BIWA 4
  • (no location specified)
Jul 29, 2014

Head and Neck Tumors Trial (99mTc - labelled hMAb BIWA 4, 186 Re - labelled hMAb BIWA 4, unlabelled hMAb BIWA 4 - low dose)

Completed
  • Head and Neck Neoplasms
  • 99mTc - labelled hMAb BIWA 4
  • +4 more
  • (no location specified)
Jul 29, 2014